Skip to content
+49 3371 6199600info@celltrend.deIm Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Contact
  • German
  • English
topbar - English
Search:
Suche
CellTrend Luckenwalde
Auftragsforschung, Antikörperdiagnostik
CellTrend LuckenwaldeCellTrend Luckenwalde
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS–CFS/ME–SFN-Long Covid
    • Information for patients
  • ELISA
    • AT1R-Antibody ELISA
      • Product information
      • Transplantation
      • Systemic sclerosis
      • Literature
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research
  • Ordering ELISA Kits
  • Company Profile
    • Newsroom
    • Board of management
    • Quality Management System
    • Referenzen
    • Partners
  • POTS–CFS/ME–SFN-Long Covid
    • Information for patients
  • ELISA
    • AT1R-Antibody ELISA
      • Product information
      • Transplantation
      • Systemic sclerosis
      • Literature
    • GPCR-Antibodies
    • In vitro Diagnostics (human)
    • Research use only
    • Food analysis
    • Contract research
    • Contract manufacturing
  • Consulting
  • Fluorescent Cells
  • Cell culture test systems
    • Oncology
    • Inflammatory test systems
    • Contract research
  • Ordering ELISA Kits

Daily Archives: 16. November 2023

You are here:
  1. Home
  2. 2023
  3. November
  4. 16

New Study about Functional Autoantibodies in Post-Acute Sequela of COVID-19 published

NewsBy celltrend celltrend16. November 2023

Post-Acute Sequela of COVID-19 (PASC) occurs after recovery from the initial illness may be triggered by autonomic dysfunction. The Postural orthostatic tachycardia syndrome (POTS) was noted in some of the 24 studied subjects of this case control study. Serum was tested for autoantibodies in controls and POTS patients. You can see in the chart, that…

+49 3371 6199600 info@celltrend.de Im Biotechnologiepark 3 TGZ II, 14943 Luckenwalde
  • Data protection declaration
  • Imprint
bottombar - English

FacebookInstagram

Go to Top
Um unsere Webseite für Sie optimal zu gestalten und fortlaufend zu verbessern, verwenden wir Cookies. Durch die weitere Nutzung der Webseite stimmen Sie deren Verwendung zu. Weitere Informationen erhalten Sie in unserer DatenschutzerklärungOK